000 | 01959 a2200553 4500 | ||
---|---|---|---|
005 | 20250518031005.0 | ||
264 | 0 | _c20200811 | |
008 | 202008s 0 0 eng d | ||
022 | _a1460-2091 | ||
024 | 7 |
_a10.1093/jac/dkz099 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMboumba Bouassa, Ralph-Sydney | |
245 | 0 | 0 |
_aHigh predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _c07 2019 |
||
300 |
_a2030-2038 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPhylogeny |
650 | 0 | 4 | _aRetreatment |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aMossoro-Kpinde, Christian Diamant | |
700 | 1 | _aGody, Jean-Chrysostome | |
700 | 1 | _aVeyer, David | |
700 | 1 | _aPéré, Hélène | |
700 | 1 | _aMatta, Mathieu | |
700 | 1 | _aRobin, Leman | |
700 | 1 | _aGrésenguet, Gérard | |
700 | 1 | _aCharpentier, Charlotte | |
700 | 1 | _aBélec, Laurent | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 74 _gno. 7 _gp. 2030-2038 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkz099 _zAvailable from publisher's website |
999 |
_c29497248 _d29497248 |